These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7299669)

  • 1. Distribution, metabolism, and elimination of phenobarbital in rats: physiologically based pharmacokinetic model.
    Engasser JM; Sarhan F; Falcoz C; Minier M; Letourneur P; Siest G
    J Pharm Sci; 1981 Nov; 70(11):1233-8. PubMed ID: 7299669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat.
    Igari Y; Sugiyama Y; Awazu S; Hanano M
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):53-75. PubMed ID: 7069578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of phenobarbital on the distribution pharmacokinetics and biological half-lives of model nonmicrosomal enzyme metabolizable sulfonamides in rats.
    Nagwekar JB; Kundu S
    J Pharm Sci; 1982 Apr; 71(4):422-6. PubMed ID: 7086650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.
    Tsuji A; Yoshikawa T; Nishide K; Minami H; Kimura M; Nakashima E; Terasaki T; Miyamoto E; Nightingale CH; Yamana T
    J Pharm Sci; 1983 Nov; 72(11):1239-52. PubMed ID: 6644585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chlorpromazine on pharmacokinetics and pharmacodynamics of phenobarbital in X-irradiated rats.
    Okulicz-Kozaryn I; Wójciakowa Z; Godlewski J; Nowakowska E
    Pol J Pharmacol Pharm; 1984; 36(1):65-71. PubMed ID: 6462962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of phenobarbital in childhood.
    Heimann G; Gladtke E
    Eur J Clin Pharmacol; 1977 Dec; 12(4):305-10. PubMed ID: 590316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenobarbital pharmacokinetics in rat as a function of age.
    Kapetanovic IM; Sweeney DJ; Rapoport SI
    Drug Metab Dispos; 1982; 10(6):586-9. PubMed ID: 6130904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse.
    Iven H; Feldbusch E
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):153-9. PubMed ID: 6139756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the intracerebral metabolism of anticonvulsant drugs--I. Perfusion of primidone through the isolated brain of the rat.
    Höller M; Penin H
    Biochem Pharmacol; 1984 Jun; 33(11):1753-6. PubMed ID: 6732842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoinduction of phenobarbital elimination in the dog.
    Abramson FP
    J Pharm Sci; 1988 Sep; 77(9):768-70. PubMed ID: 3225771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.
    Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):425-40. PubMed ID: 4087170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modeling of the anticonvulsant action of phenobarbital in rats.
    Dingemanse J; van Bree JB; Danhof M
    J Pharmacol Exp Ther; 1989 May; 249(2):601-8. PubMed ID: 2724142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenobarbital pharmacokinetics in neonates.
    Pitlick W; Painter M; Pippenger C
    Clin Pharmacol Ther; 1978 Mar; 23(3):346-50. PubMed ID: 627141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phenobarbital on the distribution pharmacokinetics and biological half-lives of model nonmetabolizable organic anions in rats.
    Szymanski DJ; Nagwekar JB
    J Pharm Sci; 1982 Mar; 71(3):275-81. PubMed ID: 7069581
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of primidone and its active metabolites in the dog.
    Frey HH; Göbel W; Löscher W
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):14-30. PubMed ID: 543743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration by perfluorodecalin of hepatic metabolism and excretion of phenobarbital.
    Huang R; Levin SS; Schleyer H; Cooper DY; Mukherji B; Sloviter HA
    Biochem Pharmacol; 1988 Oct; 37(19):3761-4. PubMed ID: 3178889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of drug action in disease states. XX. Effects of acute starvation on the pharmacodynamics of phenobarbital, ethanol and pentylenetetrazol in rats and effects of refeeding and diet composition.
    Wanwimolruk S; Levy G
    J Pharmacol Exp Ther; 1987 Jul; 242(1):166-72. PubMed ID: 3612521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
    Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
    J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.